<html>
<head>PUBMED IDs for OCC1</head>
<body bgcolor='#C5F0F2'><h1>OCC1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10684788/'>Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer.</a> February 24  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10952922/'>Expression and action of transforming growth factor alpha in normal ovarian surface epithelium and ovarian cancer.</a> August 23  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11000522/'>Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer.</a> September 23  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15378028/'>Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.</a> September 21  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15671249/'>Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.</a> January 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18802925/'>Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway.</a> September 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22065864/'>Differential expression patterns of striate cortex-enriched genes among Old World, New World, and prosimian primates.</a> February 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24086535/'>The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cells.</a> July 8  2013<br></body></html>
